Pharma

1 article

Diverse group of executives in a modern biotech boardroom discussing genetic sequences and financial data, symbolizing leadership changes and innovation.

STAT Plus Reports on Major Executive Leadership Changes

Dr. Anya Sharma, former head of R&D at BioGen Corp, a major pharmaceutical player, abruptly left her post to become CEO of GenePath, a gene-editing startup that recently secured $150M in Series B fund

David Grossman·June 13, 2026